Raymond James & Associates’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,325
| Closed | -$196K | – | 3940 |
|
|
2021
Q4 | $196K | Buy |
+15,325
| New | +$196K | ﹤0.01% | 3675 |
|
|
2020
Q2 | – | Sell |
-170,868
| Closed | -$613K | – | 3399 |
|
|
2020
Q1 | $613K | Buy |
170,868
+9,460
| +6% | +$33.9K | ﹤0.01% | 2278 |
|
|
2019
Q4 | $1.37M | Sell |
161,408
-4,630
| -3% | -$39.2K | ﹤0.01% | 2073 |
|
|
2019
Q3 | $1.12M | Buy |
166,038
+8,750
| +6% | +$59.2K | ﹤0.01% | 2131 |
|
|
2019
Q2 | $1.06M | Buy |
157,288
+25,000
| +19% | +$168K | ﹤0.01% | 2178 |
|
|
2019
Q1 | $835K | Hold |
132,288
| – | – | ﹤0.01% | 2310 |
|
|
2018
Q4 | $857K | Hold |
132,288
| – | – | ﹤0.01% | 2173 |
|
|
2018
Q3 | $939K | Buy |
132,288
+14,288
| +12% | +$101K | ﹤0.01% | 2290 |
|
|
2018
Q2 | $513K | Hold |
118,000
| – | – | ﹤0.01% | 2659 |
|
|
2018
Q1 | $350K | Hold |
118,000
| – | – | ﹤0.01% | 2782 |
|
|
2017
Q4 | $307K | Buy |
+118,000
| New | +$307K | ﹤0.01% | 2804 |
|